Impersonalized medicine.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 22399263.
- Also identified by DOI 10.1126/scitranslmed.3003738.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Research reported in this issue of Science Translational Medicine illustrates the benefits of short-term food withdrawal (fasting) in the treatment of cancer. Fasting exploited fundamental differences in the way tumor cells and normal cells respond to stress, simultaneously strengthening normal cell function and weakening tumor cell survival in the presence of toxic doses of chemotherapeutic drugs.
Medical subject headings
- Antineoplastic Agents
- Fasting
- Neoplasms